Skip to main content
Premium Trial:

Request an Annual Quote

Ardais Licenses BIGR Library to Drug Company Xantos

NEW YORK, May 15 - German drug discoverer Xantos Biomedicine will use Ardais' BIGR tissue library to help it clinically validate drug targets in inflammatory and degenerative diseases, the companies said today.

The BIGR library contains more than 10,000 patient cases comprising more than 160,000 tissue samples and associated clinical information, according to Ardais.

 

Click here for more information.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.